Medigen Vaccine Biologics Corporation (TPEX:6547)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
36.05
+0.50 (1.41%)
Mar 10, 2026, 10:10 AM CST

Medigen Vaccine Biologics Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Market Capitalization
11,68711,85123,03522,78563,65321,743
Upgrade
Market Cap Growth
-30.70%-48.55%1.10%-64.20%192.75%388.97%
Upgrade
Enterprise Value
10,31210,38221,27120,54062,66022,145
Upgrade
Last Close Price
35.5536.0570.1069.50200.9169.21
Upgrade
PE Ratio
----45.14-
Upgrade
PS Ratio
19.6419.5759.1262.4219.401889.56
Upgrade
PB Ratio
3.243.085.994.5313.616.92
Upgrade
P/TBV Ratio
3.263.106.054.5713.777.06
Upgrade
P/FCF Ratio
-1835.64--142.64-
Upgrade
P/OCF Ratio
486.92290.80--109.77-
Upgrade
EV/Sales Ratio
17.3317.1454.5956.2719.101924.50
Upgrade
EV/EBITDA Ratio
----58.45-
Upgrade
EV/EBIT Ratio
----65.02-
Upgrade
EV/FCF Ratio
-364.561608.05--140.41-
Upgrade
Debt / Equity Ratio
0.080.090.510.390.040.06
Upgrade
Debt / EBITDA Ratio
----0.17-
Upgrade
Debt / FCF Ratio
-52.50--0.42-
Upgrade
Net Debt / Equity Ratio
-0.38-0.41-0.46-0.45-0.44-0.49
Upgrade
Net Debt / EBITDA Ratio
29.1860.261.621.60-1.912.36
Upgrade
Net Debt / FCF Ratio
48.62-244.213.421.69-4.592.24
Upgrade
Asset Turnover
0.140.120.060.060.750.00
Upgrade
Inventory Turnover
0.580.500.250.762.840.09
Upgrade
Quick Ratio
10.989.541.9912.486.5411.58
Upgrade
Current Ratio
14.1211.942.2115.388.4812.48
Upgrade
Return on Equity (ROE)
-4.44%-2.09%-26.14%-30.39%36.08%-29.91%
Upgrade
Return on Assets (ROA)
-2.50%-1.74%-11.29%-15.18%13.71%-16.55%
Upgrade
Return on Capital Employed (ROCE)
-4.30%-3.50%-29.60%-22.00%19.80%-22.90%
Upgrade
Earnings Yield
-1.42%-0.68%-5.04%-6.47%2.22%-3.10%
Upgrade
FCF Yield
-0.24%0.05%-2.26%-5.94%0.70%-3.17%
Upgrade
Buyback Yield / Dilution
-0.01%-0.10%-1.50%-0.73%-15.82%-20.08%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.